In addition, drugs such as edrecolomab and catumaxomab that target epithelial cell adhesion molecule (EpCAM), a surface protein found to be specifically expressed on exosomes isolated from PC patients, have been used in antitumor studies[97]. This evidence concerns the gene EPCAM and pachyonychia congenita.